Iraq

Iraq

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
0.14 (0.11 - 0.18) 2015 Modelled WHO
3.5 (3.20 - 3.90) 2016 Modelled Razavi-Shearer et al, 2018
0.67 (0.65 - 0.70) 2013 Modelled Schweitzer et al, 2015
1.98 (1.62 - 2.31) 2019 Modelled IHME, GBD 2019 (accessed 2020)
2.28 (1.90 - 2.65) 2018 Modelled IHME, GBD 2019 (accessed 2022)
2.34 (1.96 - 2.76) 2017 Modelled IHME, GBD 2019 (accessed 2022)
2.34 (1.96 - 2.71) 2016 Modelled IHME, GBD 2019 (accessed 2022)
2.34 (1.96 - 2.71) 2015 Modelled IHME, GBD 2019 (accessed 2022)
2.39 (2 - 2.75) 2014 Modelled IHME, GBD 2019 (accessed 2022)
2.48 (2.06 - 2.86) 2013 Modelled IHME, GBD 2019 (accessed 2022)
2.58 (2.13 - 2.99) 2012 Modelled IHME, GBD 2019 (accessed 2022)
2.67 (2.18 - 3.13) 2011 Modelled IHME, GBD 2019 (accessed 2022)
2.73 (2.21 - 3.24) 2010 Modelled IHME, GBD 2019 (accessed 2022)
2.77 (2.24 - 3.27) 2009 Modelled IHME, GBD 2019 (accessed 2022)
2.84 (2.30 - 3.35) 2008 Modelled IHME, GBD 2019 (accessed 2022)
2.91 (2.36 - 3.44) 2007 Modelled IHME, GBD 2019 (accessed 2022)
2.98 (2.41 - 3.53) 2006 Modelled IHME, GBD 2019 (accessed 2022)
3.02 (2.46 - 3.61) 2005 Modelled IHME, GBD 2019 (accessed 2022)
3.08 (2.50 - 3.63) 2004 Modelled IHME, GBD 2019 (accessed 2022)
3.15 (2.56 - 3.73) 2003 Modelled IHME, GBD 2019 (accessed 2022)
3.24 (2.61 - 3.82) 2002 Modelled IHME, GBD 2019 (accessed 2022)
3.32 (2.67 - 3.92) 2001 Modelled IHME, GBD 2019 (accessed 2022)
3.39 (2.69 - 4.03) 2000 Modelled IHME, GBD 2019 (accessed 2022)
3.46 (2.78 - 4.08) 1999 Modelled IHME, GBD 2019 (accessed 2022)
3.56 (2.87 - 4.20) 1998 Modelled IHME, GBD 2019 (accessed 2022)
3.67 (2.96 - 4.34) 1997 Modelled IHME, GBD 2019 (accessed 2022)
3.77 (3.05 - 4.48) 1996 Modelled IHME, GBD 2019 (accessed 2022)
3.83 (3.10 - 4.58) 1995 Modelled IHME, GBD 2019 (accessed 2022)
3.87 (3.16 - 4.62) 1994 Modelled IHME, GBD 2019 (accessed 2022)
3.93 (3.23 - 4.68) 1993 Modelled IHME, GBD 2019 (accessed 2022)
3.99 (3.29 - 4.77) 1992 Modelled IHME, GBD 2019 (accessed 2022)
4.06 (3.35 - 4.85) 1991 Modelled IHME, GBD 2019 (accessed 2022)
4.13 (3.39 - 4.97) 1990 Modelled IHME, GBD 2019 (accessed 2022)
2.15 (1.77 - 2.51) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.06 (0.04 - 0.08) 2015 Modelled WHO
0.43 (0.31 - 0.56) 2019 Modelled IHME, GBD 2019 (accessed 2020)
0.53 (0.39 - 0.69) 2019 Modelled IHME, GBD 2019 (accessed 2022)
0.77 (0.58 - 0.99) 2018 Modelled IHME, GBD 2019 (accessed 2022)
0.91 (0.67 - 1.18) 2017 Modelled IHME, GBD 2019 (accessed 2022)
0.97 (0.74 - 1.25) 2016 Modelled IHME, GBD 2019 (accessed 2022)
1 (0.76 - 1.29) 2015 Modelled IHME, GBD 2019 (accessed 2022)
0.99 (0.75 - 1.26) 2014 Modelled IHME, GBD 2019 (accessed 2022)
0.97 (0.73 - 1.24) 2013 Modelled IHME, GBD 2019 (accessed 2022)
0.94 (0.71 - 1.22) 2012 Modelled IHME, GBD 2019 (accessed 2022)
0.92 (0.68 - 1.19) 2011 Modelled IHME, GBD 2019 (accessed 2022)
0.91 (0.66 - 1.18) 2010 Modelled IHME, GBD 2019 (accessed 2022)
0.93 (0.68 - 1.21) 2009 Modelled IHME, GBD 2019 (accessed 2022)
1 (0.73 - 1.29) 2008 Modelled IHME, GBD 2019 (accessed 2022)
1.08 (0.79 - 1.41) 2007 Modelled IHME, GBD 2019 (accessed 2022)
1.17 (0.85 - 1.53) 2006 Modelled IHME, GBD 2019 (accessed 2022)
1.25 (0.89 - 1.61) 2005 Modelled IHME, GBD 2019 (accessed 2022)
1.31 (0.95 - 1.69) 2004 Modelled IHME, GBD 2019 (accessed 2022)
1.36 (0.99 - 1.74) 2003 Modelled IHME, GBD 2019 (accessed 2022)
1.41 (1.04 - 1.80) 2002 Modelled IHME, GBD 2019 (accessed 2022)
1.47 (1.10 - 1.89) 2001 Modelled IHME, GBD 2019 (accessed 2022)
1.54 (1.14 - 1.99) 2000 Modelled IHME, GBD 2019 (accessed 2022)
1.67 (1.26 - 2.15) 1999 Modelled IHME, GBD 2019 (accessed 2022)
1.86 (1.39 - 2.37) 1998 Modelled IHME, GBD 2019 (accessed 2022)
2.06 (1.54 - 2.62) 1997 Modelled IHME, GBD 2019 (accessed 2022)
2.23 (1.65 - 2.84) 1996 Modelled IHME, GBD 2019 (accessed 2022)
2.31 (1.70 - 2.98) 1995 Modelled IHME, GBD 2019 (accessed 2022)
2.33 (1.72 - 3) 1994 Modelled IHME, GBD 2019 (accessed 2022)
2.34 (1.75 - 3.02) 1993 Modelled IHME, GBD 2019 (accessed 2022)
2.36 (1.75 - 3.03) 1992 Modelled IHME, GBD 2019 (accessed 2022)
2.36 (1.77 - 3.08) 1991 Modelled IHME, GBD 2019 (accessed 2022)
2.37 (1.76 - 3.10) 1990 Modelled IHME, GBD 2019 (accessed 2022)
0.29 (0.14 - 0.54) 2020 Modelled WHO
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
1,302,000 (1,189,000 - 1,460,000) 2016 Modelled Razavi-Shearer et al, 2018
832,569 (684,280 - 972,494) 2019 Modelled IHME, GBD 2019 (accessed 2020)
855,534 (703,880 - 997,317) 2019 Modelled IHME, GBD 2019 (accessed 2022)
889,870 (742,754 - 1,031,750) 2018 Modelled IHME, GBD 2019 (accessed 2022)
895,856 (752,551 - 1,055,960) 2017 Modelled IHME, GBD 2019 (accessed 2022)
878,152 (738,814 - 1,018,620) 2016 Modelled IHME, GBD 2019 (accessed 2022)
862,636 (716,471 - 993,923) 2015 Modelled IHME, GBD 2019 (accessed 2022)
863,988 (721,092 - 994,343) 2014 Modelled IHME, GBD 2019 (accessed 2022)
877,705 (732,848 - 1,013,460) 2013 Modelled IHME, GBD 2019 (accessed 2022)
889,986 (739,850 - 1,032,020) 2012 Modelled IHME, GBD 2019 (accessed 2022)
889,156 (727,278 - 1,039,880) 2011 Modelled IHME, GBD 2019 (accessed 2022)
873,401 (707,974 - 1,037,300) 2010 Modelled IHME, GBD 2019 (accessed 2022)
860,289 (696,734 - 1,016,550) 2009 Modelled IHME, GBD 2019 (accessed 2022)
858,181 (692,678 - 1,009,600) 2008 Modelled IHME, GBD 2019 (accessed 2022)
854,461 (692,053 - 1,009,760) 2007 Modelled IHME, GBD 2019 (accessed 2022)
851,086 (691,356 - 1,009,070) 2006 Modelled IHME, GBD 2019 (accessed 2022)
860,253 (699,441 - 1,027,490) 2005 Modelled IHME, GBD 2019 (accessed 2022)
873,746 (710,667 - 1,029,940) 2004 Modelled IHME, GBD 2019 (accessed 2022)
876,051 (711,616 - 1,034,780) 2003 Modelled IHME, GBD 2019 (accessed 2022)
874,431 (707,701 - 1,028,970) 2002 Modelled IHME, GBD 2019 (accessed 2022)
871,398 (698,805 - 1,030,490) 2001 Modelled IHME, GBD 2019 (accessed 2022)
859,415 (685,078 - 1,020,920) 2000 Modelled IHME, GBD 2019 (accessed 2022)
848,189 (682,365 - 1,003,860) 1999 Modelled IHME, GBD 2019 (accessed 2022)
843,689 (681,643 - 996,408) 1998 Modelled IHME, GBD 2019 (accessed 2022)
839,753 (677,252 - 994,308) 1997 Modelled IHME, GBD 2019 (accessed 2022)
831,543 (673,876 - 987,075) 1996 Modelled IHME, GBD 2019 (accessed 2022)
815,098 (659,403 - 976,816) 1995 Modelled IHME, GBD 2019 (accessed 2022)
795,502 (650,964 - 947,056) 1994 Modelled IHME, GBD 2019 (accessed 2022)
777,905 (640,337 - 928,403) 1993 Modelled IHME, GBD 2019 (accessed 2022)
755,398 (623,808 - 898,131) 1992 Modelled IHME, GBD 2019 (accessed 2022)
715,746 (592,103 - 856,071) 1991 Modelled IHME, GBD 2019 (accessed 2022)
684,414 (567,019 - 822,179) 1990 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
2.6 (1.90 - 3.47) 2019 Modelled IHME, GBD 2019 (accessed 2020)
3.39 (2.55 - 4.51) 1991 Modelled IHME, GBD 2019 (accessed 2022)
3.47 (2.64 - 4.58) 1990 Modelled IHME, GBD 2019 (accessed 2022)
3.29 (2.45 - 4.40) 1992 Modelled IHME, GBD 2019 (accessed 2022)
3.23 (2.36 - 4.33) 1993 Modelled IHME, GBD 2019 (accessed 2022)
3.17 (2.30 - 4.28) 1994 Modelled IHME, GBD 2019 (accessed 2022)
3.14 (2.25 - 4.24) 1995 Modelled IHME, GBD 2019 (accessed 2022)
3.08 (2.21 - 4.19) 1996 Modelled IHME, GBD 2019 (accessed 2022)
2.96 (2.09 - 4.07) 1997 Modelled IHME, GBD 2019 (accessed 2022)
2.8 (1.96 - 3.87) 1998 Modelled IHME, GBD 2019 (accessed 2022)
2.65 (1.84 - 3.70) 1999 Modelled IHME, GBD 2019 (accessed 2022)
2.56 (1.76 - 3.59) 2000 Modelled IHME, GBD 2019 (accessed 2022)
2.51 (1.72 - 3.54) 2001 Modelled IHME, GBD 2019 (accessed 2022)
2.49 (1.71 - 3.49) 2002 Modelled IHME, GBD 2019 (accessed 2022)
2.49 (1.73 - 3.48) 2003 Modelled IHME, GBD 2019 (accessed 2022)
2.53 (1.80 - 3.44) 2005 Modelled IHME, GBD 2019 (accessed 2022)
2.56 (1.83 - 3.47) 2006 Modelled IHME, GBD 2019 (accessed 2022)
2.48 (1.75 - 3.43) 2004 Modelled IHME, GBD 2019 (accessed 2022)
2.55 (1.84 - 3.42) 2007 Modelled IHME, GBD 2019 (accessed 2022)
2.6 (1.90 - 3.48) 2008 Modelled IHME, GBD 2019 (accessed 2022)
2.55 (1.86 - 3.43) 2009 Modelled IHME, GBD 2019 (accessed 2022)
2.56 (1.88 - 3.40) 2010 Modelled IHME, GBD 2019 (accessed 2022)
2.56 (1.87 - 3.37) 2011 Modelled IHME, GBD 2019 (accessed 2022)
2.58 (1.90 - 3.35) 2012 Modelled IHME, GBD 2019 (accessed 2022)
2.64 (1.93 - 3.47) 2013 Modelled IHME, GBD 2019 (accessed 2022)
2.67 (1.94 - 3.53) 2014 Modelled IHME, GBD 2019 (accessed 2022)
2.62 (1.91 - 3.51) 2015 Modelled IHME, GBD 2019 (accessed 2022)
2.59 (1.87 - 3.48) 2016 Modelled IHME, GBD 2019 (accessed 2022)
2.6 (1.89 - 3.46) 2017 Modelled IHME, GBD 2019 (accessed 2022)
2.62 (1.91 - 3.52) 2018 Modelled IHME, GBD 2019 (accessed 2022)
2.6 (1.90 - 3.47) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
964 2016 Modelled WHO
633 (477 - 843) 1991 Modelled IHME, GBD 2019 (accessed 2022)
611 (464 - 806) 1990 Modelled IHME, GBD 2019 (accessed 2022)
678 (495 - 910) 1993 Modelled IHME, GBD 2019 (accessed 2022)
660 (491 - 883) 1992 Modelled IHME, GBD 2019 (accessed 2022)
691 (501 - 931) 1994 Modelled IHME, GBD 2019 (accessed 2022)
709 (508 - 956) 1995 Modelled IHME, GBD 2019 (accessed 2022)
720 (516 - 979) 1996 Modelled IHME, GBD 2019 (accessed 2022)
704 (491 - 973) 1998 Modelled IHME, GBD 2019 (accessed 2022)
716 (505 - 986) 1997 Modelled IHME, GBD 2019 (accessed 2022)
691 (478 - 963) 1999 Modelled IHME, GBD 2019 (accessed 2022)
689 (473 - 966) 2000 Modelled IHME, GBD 2019 (accessed 2022)
699 (477 - 985) 2001 Modelled IHME, GBD 2019 (accessed 2022)
712 (490 - 998) 2002 Modelled IHME, GBD 2019 (accessed 2022)
734 (511 - 1,026) 2003 Modelled IHME, GBD 2019 (accessed 2022)
748 (527 - 1,034) 2004 Modelled IHME, GBD 2019 (accessed 2022)
794 (574 - 1,065) 2007 Modelled IHME, GBD 2019 (accessed 2022)
776 (556 - 1,051) 2006 Modelled IHME, GBD 2019 (accessed 2022)
763 (543 - 1,039) 2005 Modelled IHME, GBD 2019 (accessed 2022)
834 (610 - 1,115) 2008 Modelled IHME, GBD 2019 (accessed 2022)
838 (611 - 1,131) 2009 Modelled IHME, GBD 2019 (accessed 2022)
872 (639 - 1,156) 2010 Modelled IHME, GBD 2019 (accessed 2022)
904 (662 - 1,189) 2011 Modelled IHME, GBD 2019 (accessed 2022)
944 (696 - 1,226) 2012 Modelled IHME, GBD 2019 (accessed 2022)
991 (726 - 1,305) 2013 Modelled IHME, GBD 2019 (accessed 2022)
1,022 (743 - 1,367) 2015 Modelled IHME, GBD 2019 (accessed 2022)
1,021 (743 - 1,351) 2014 Modelled IHME, GBD 2019 (accessed 2022)
1,031 (744 - 1,385) 2016 Modelled IHME, GBD 2019 (accessed 2022)
1,083 (790 - 1,454) 2018 Modelled IHME, GBD 2019 (accessed 2022)
1,054 (765 - 1,402) 2017 Modelled IHME, GBD 2019 (accessed 2022)
1,094 (801 - 1,460) 2019 Modelled IHME, GBD 2019 (accessed 2022)
1,094 (801 - 1,460) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
11 (8 - 15) 1991 Modelled IHME, GBD 2019 (accessed 2022)
11 (8 - 15) 1990 Modelled IHME, GBD 2019 (accessed 2022)
11 (8 - 15) 1993 Modelled IHME, GBD 2019 (accessed 2022)
11 (8 - 15) 1992 Modelled IHME, GBD 2019 (accessed 2022)
12 (9 - 15) 1994 Modelled IHME, GBD 2019 (accessed 2022)
12 (9 - 16) 1995 Modelled IHME, GBD 2019 (accessed 2022)
12 (9 - 16) 1998 Modelled IHME, GBD 2019 (accessed 2022)
12 (9 - 16) 1996 Modelled IHME, GBD 2019 (accessed 2022)
12 (9 - 16) 1997 Modelled IHME, GBD 2019 (accessed 2022)
12 (9 - 16) 1999 Modelled IHME, GBD 2019 (accessed 2022)
13 (9 - 17) 2000 Modelled IHME, GBD 2019 (accessed 2022)
13 (10 - 17) 2001 Modelled IHME, GBD 2019 (accessed 2022)
14 (10 - 18) 2002 Modelled IHME, GBD 2019 (accessed 2022)
13 (10 - 16) 2003 Modelled IHME, GBD 2019 (accessed 2022)
13 (10 - 16) 2004 Modelled IHME, GBD 2019 (accessed 2022)
13 (10 - 16) 2005 Modelled IHME, GBD 2019 (accessed 2022)
12 (9 - 15) 2006 Modelled IHME, GBD 2019 (accessed 2022)
12 (9 - 15) 2007 Modelled IHME, GBD 2019 (accessed 2022)
16 (13 - 20) 2009 Modelled IHME, GBD 2019 (accessed 2022)
15 (12 - 19) 2008 Modelled IHME, GBD 2019 (accessed 2022)
18 (14 - 22) 2010 Modelled IHME, GBD 2019 (accessed 2022)
19 (15 - 24) 2011 Modelled IHME, GBD 2019 (accessed 2022)
21 (17 - 27) 2012 Modelled IHME, GBD 2019 (accessed 2022)
23 (18 - 29) 2013 Modelled IHME, GBD 2019 (accessed 2022)
22 (17 - 29) 2014 Modelled IHME, GBD 2019 (accessed 2022)
23 (17 - 30) 2015 Modelled IHME, GBD 2019 (accessed 2022)
23 (17 - 30) 2016 Modelled IHME, GBD 2019 (accessed 2022)
23 (17 - 31) 2017 Modelled IHME, GBD 2019 (accessed 2022)
27 (20 - 36) 2019 Modelled IHME, GBD 2019 (accessed 2022)
27 (20 - 36) 2018 Modelled IHME, GBD 2019 (accessed 2022)
36 (28 - 46) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Coverage of HepB birth dose

Newborns
Download
Value (%) Year Type Source
41 2019 Survey/reported WHO/UNICEF
41 2018 Survey/reported WHO/UNICEF
44 2017 Survey/reported WHO/UNICEF
47 2016 Survey/reported WHO/UNICEF
43 2015 Survey/reported WHO/UNICEF
43 2014 Survey/reported WHO/UNICEF
43 2013 Survey/reported WHO/UNICEF
37 2012 Survey/reported WHO/UNICEF
32 2011 Survey/reported WHO/UNICEF
27 2010 Survey/reported WHO/UNICEF
60 2009 Survey/reported WHO/UNICEF
92 2008 Survey/reported WHO/UNICEF
90 2007 Survey/reported WHO/UNICEF
88 2006 Survey/reported WHO/UNICEF
93 2005 Survey/reported WHO/UNICEF
92 2004 Survey/reported WHO/UNICEF
47 2020 Survey/reported WHO/UNICEF
48 2021 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
84 2019 Survey/reported WHO/UNICEF
74 2020 Survey/reported WHO/UNICEF
78 2021 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2017
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes
Source: WHO
Year of birth dose introduction
2004
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
No
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
No
Source: Harm Reduction International
NSP in at least one prison
No
Source: Harm Reduction International
OST in at least one prison
No
Source: Harm Reduction International
% of substance use disorder facilities offering hepatitis testing
Most (61-100%)
Source: WHO
% of substance use disorder facilities offering hepatitis treatment
Most (61-100%)
Source: WHO

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
0.2 (0.20 - 0.30) 2015 Modelled Blach et al, 2017
1.16 (0.94 - 1.45) 2019 Modelled IHME, GBD 2019 (accessed 2022)
1.16 (0.93 - 1.44) 2018 Modelled IHME, GBD 2019 (accessed 2022)
1.16 (0.93 - 1.44) 2017 Modelled IHME, GBD 2019 (accessed 2022)
1.21 (0.98 - 1.47) 2016 Modelled IHME, GBD 2019 (accessed 2022)
1.26 (1.03 - 1.52) 2015 Modelled IHME, GBD 2019 (accessed 2022)
1.2 (0.99 - 1.46) 2014 Modelled IHME, GBD 2019 (accessed 2022)
1.1 (0.91 - 1.33) 2013 Modelled IHME, GBD 2019 (accessed 2022)
0.98 (0.81 - 1.18) 2012 Modelled IHME, GBD 2019 (accessed 2022)
0.89 (0.73 - 1.07) 2011 Modelled IHME, GBD 2019 (accessed 2022)
0.85 (0.69 - 1.02) 2010 Modelled IHME, GBD 2019 (accessed 2022)
0.84 (0.69 - 1.02) 2009 Modelled IHME, GBD 2019 (accessed 2022)
0.85 (0.69 - 1.03) 2008 Modelled IHME, GBD 2019 (accessed 2022)
0.85 (0.70 - 1.04) 2007 Modelled IHME, GBD 2019 (accessed 2022)
0.86 (0.70 - 1.04) 2006 Modelled IHME, GBD 2019 (accessed 2022)
0.86 (0.70 - 1.04) 2005 Modelled IHME, GBD 2019 (accessed 2022)
0.85 (0.69 - 1.03) 2004 Modelled IHME, GBD 2019 (accessed 2022)
0.84 (0.68 - 1.02) 2003 Modelled IHME, GBD 2019 (accessed 2022)
0.83 (0.67 - 1.01) 2002 Modelled IHME, GBD 2019 (accessed 2022)
0.82 (0.67 - 1) 2001 Modelled IHME, GBD 2019 (accessed 2022)
0.82 (0.66 - 1) 2000 Modelled IHME, GBD 2019 (accessed 2022)
0.86 (0.70 - 1.06) 1999 Modelled IHME, GBD 2019 (accessed 2022)
0.96 (0.78 - 1.17) 1998 Modelled IHME, GBD 2019 (accessed 2022)
1.08 (0.87 - 1.32) 1997 Modelled IHME, GBD 2019 (accessed 2022)
1.18 (0.95 - 1.45) 1996 Modelled IHME, GBD 2019 (accessed 2022)
1.22 (0.98 - 1.51) 1995 Modelled IHME, GBD 2019 (accessed 2022)
1.23 (0.99 - 1.54) 1994 Modelled IHME, GBD 2019 (accessed 2022)
1.24 (1 - 1.55) 1993 Modelled IHME, GBD 2019 (accessed 2022)
1.25 (1.01 - 1.56) 1992 Modelled IHME, GBD 2019 (accessed 2022)
1.27 (1.02 - 1.58) 1991 Modelled IHME, GBD 2019 (accessed 2022)
1.28 (1.03 - 1.60) 1990 Modelled IHME, GBD 2019 (accessed 2022)
1.09 (0.88 - 1.36) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value (%) Year Type Source
0.38 (0.27 - 0.43) 2019 Modelled Dugan et al., 2021
Technical notes

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
3.2 (0.30 - 3.20) 2014 Survey/reported Gower et al, 2014
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
85,000 (60,000 - 97,000) 2015 Modelled Blach et al, 2017
212,964 (170,789 - 265,569) 1990 Modelled IHME, GBD 2019 (accessed 2022)
224,246 (180,208 - 278,823) 1991 Modelled IHME, GBD 2019 (accessed 2022)
237,436 (190,702 - 294,682) 1992 Modelled IHME, GBD 2019 (accessed 2022)
246,368 (197,434 - 305,371) 1993 Modelled IHME, GBD 2019 (accessed 2022)
253,541 (202,340 - 313,660) 1994 Modelled IHME, GBD 2019 (accessed 2022)
260,273 (208,012 - 321,273) 1995 Modelled IHME, GBD 2019 (accessed 2022)
259,125 (207,554 - 318,910) 1996 Modelled IHME, GBD 2019 (accessed 2022)
246,089 (198,910 - 301,906) 1997 Modelled IHME, GBD 2019 (accessed 2022)
227,808 (185,269 - 278,406) 1998 Modelled IHME, GBD 2019 (accessed 2022)
212,261 (172,817 - 258,539) 1999 Modelled IHME, GBD 2019 (accessed 2022)
208,816 (169,305 - 254,035) 2000 Modelled IHME, GBD 2019 (accessed 2022)
215,809 (175,367 - 261,927) 2001 Modelled IHME, GBD 2019 (accessed 2022)
223,841 (181,859 - 271,586) 2002 Modelled IHME, GBD 2019 (accessed 2022)
232,861 (188,875 - 282,345) 2003 Modelled IHME, GBD 2019 (accessed 2022)
240,790 (196,616 - 291,422) 2004 Modelled IHME, GBD 2019 (accessed 2022)
244,058 (198,950 - 295,770) 2005 Modelled IHME, GBD 2019 (accessed 2022)
246,075 (201,068 - 297,623) 2006 Modelled IHME, GBD 2019 (accessed 2022)
250,862 (205,501 - 303,552) 2007 Modelled IHME, GBD 2019 (accessed 2022)
256,310 (210,053 - 309,866) 2008 Modelled IHME, GBD 2019 (accessed 2022)
262,072 (214,356 - 315,829) 2009 Modelled IHME, GBD 2019 (accessed 2022)
271,245 (222,205 - 328,044) 2010 Modelled IHME, GBD 2019 (accessed 2022)
296,178 (242,941 - 355,531) 2011 Modelled IHME, GBD 2019 (accessed 2022)
339,927 (279,780 - 408,186) 2012 Modelled IHME, GBD 2019 (accessed 2022)
390,303 (321,265 - 469,659) 2013 Modelled IHME, GBD 2019 (accessed 2022)
435,435 (357,335 - 527,076) 2014 Modelled IHME, GBD 2019 (accessed 2022)
462,882 (378,148 - 561,920) 2015 Modelled IHME, GBD 2019 (accessed 2022)
454,509 (370,703 - 555,729) 2016 Modelled IHME, GBD 2019 (accessed 2022)
443,125 (356,624 - 552,077) 2017 Modelled IHME, GBD 2019 (accessed 2022)
452,699 (364,723 - 565,048) 2018 Modelled IHME, GBD 2019 (accessed 2022)
459,549 (371,947 - 571,602) 2019 Modelled IHME, GBD 2019 (accessed 2020)
463,503 (375,397 - 575,649) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value Year Type Source
37,800 (26,800 - 42,900) 2019 Modelled Dugan et al., 2021

HCV-related death rate

National
Download
Value (Deaths per 100,000) Year Type Source
3.94 (2.89 - 5.11) 2019 Modelled IHME, GBD 2019 (accessed 2020)
3.53 (2.68 - 4.59) 1991 Modelled IHME, GBD 2019 (accessed 2022)
3.63 (2.74 - 4.71) 1990 Modelled IHME, GBD 2019 (accessed 2022)
3.44 (2.60 - 4.52) 1992 Modelled IHME, GBD 2019 (accessed 2022)
3.4 (2.52 - 4.50) 1993 Modelled IHME, GBD 2019 (accessed 2022)
3.37 (2.49 - 4.47) 1994 Modelled IHME, GBD 2019 (accessed 2022)
3.38 (2.49 - 4.48) 1995 Modelled IHME, GBD 2019 (accessed 2022)
3.38 (2.47 - 4.48) 1996 Modelled IHME, GBD 2019 (accessed 2022)
3.35 (2.39 - 4.55) 1998 Modelled IHME, GBD 2019 (accessed 2022)
3.38 (2.44 - 4.54) 1997 Modelled IHME, GBD 2019 (accessed 2022)
3.3 (2.34 - 4.54) 1999 Modelled IHME, GBD 2019 (accessed 2022)
3.24 (2.29 - 4.46) 2000 Modelled IHME, GBD 2019 (accessed 2022)
3.18 (2.23 - 4.34) 2001 Modelled IHME, GBD 2019 (accessed 2022)
3.14 (2.21 - 4.32) 2002 Modelled IHME, GBD 2019 (accessed 2022)
3.15 (2.22 - 4.34) 2003 Modelled IHME, GBD 2019 (accessed 2022)
3.14 (2.21 - 4.27) 2004 Modelled IHME, GBD 2019 (accessed 2022)
3.2 (2.29 - 4.37) 2005 Modelled IHME, GBD 2019 (accessed 2022)
3.27 (2.39 - 4.41) 2006 Modelled IHME, GBD 2019 (accessed 2022)
3.34 (2.47 - 4.47) 2007 Modelled IHME, GBD 2019 (accessed 2022)
3.5 (2.60 - 4.60) 2008 Modelled IHME, GBD 2019 (accessed 2022)
3.53 (2.64 - 4.65) 2009 Modelled IHME, GBD 2019 (accessed 2022)
3.62 (2.68 - 4.75) 2010 Modelled IHME, GBD 2019 (accessed 2022)
3.67 (2.72 - 4.75) 2012 Modelled IHME, GBD 2019 (accessed 2022)
3.74 (2.77 - 4.87) 2013 Modelled IHME, GBD 2019 (accessed 2022)
3.64 (2.67 - 4.75) 2011 Modelled IHME, GBD 2019 (accessed 2022)
3.72 (2.74 - 4.82) 2015 Modelled IHME, GBD 2019 (accessed 2022)
3.76 (2.79 - 4.89) 2014 Modelled IHME, GBD 2019 (accessed 2022)
3.68 (2.68 - 4.78) 2016 Modelled IHME, GBD 2019 (accessed 2022)
3.71 (2.65 - 4.89) 2017 Modelled IHME, GBD 2019 (accessed 2022)
3.94 (2.89 - 5.11) 2019 Modelled IHME, GBD 2019 (accessed 2022)
3.82 (2.75 - 4.99) 2018 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
415 2016 Modelled WHO
1,660 (1,217 - 2,152) 2019 Modelled IHME, GBD 2019 (accessed 2022)
1,660 (1,217 - 2,152) 2019 Modelled IHME, GBD 2019 (accessed 2020)
1,580 (1,137 - 2,063) 2018 Modelled IHME, GBD 2019 (accessed 2022)
1,504 (1,076 - 1,981) 2017 Modelled IHME, GBD 2019 (accessed 2022)
1,464 (1,067 - 1,900) 2016 Modelled IHME, GBD 2019 (accessed 2022)
1,450 (1,069 - 1,881) 2015 Modelled IHME, GBD 2019 (accessed 2022)
1,442 (1,067 - 1,872) 2014 Modelled IHME, GBD 2019 (accessed 2022)
1,404 (1,040 - 1,827) 2013 Modelled IHME, GBD 2019 (accessed 2022)
1,342 (997 - 1,737) 2012 Modelled IHME, GBD 2019 (accessed 2022)
1,285 (944 - 1,678) 2011 Modelled IHME, GBD 2019 (accessed 2022)
1,230 (910 - 1,614) 2010 Modelled IHME, GBD 2019 (accessed 2022)
1,163 (870 - 1,531) 2009 Modelled IHME, GBD 2019 (accessed 2022)
1,122 (835 - 1,475) 2008 Modelled IHME, GBD 2019 (accessed 2022)
1,042 (770 - 1,392) 2007 Modelled IHME, GBD 2019 (accessed 2022)
992 (725 - 1,339) 2006 Modelled IHME, GBD 2019 (accessed 2022)
966 (692 - 1,320) 2005 Modelled IHME, GBD 2019 (accessed 2022)
946 (666 - 1,285) 2004 Modelled IHME, GBD 2019 (accessed 2022)
927 (655 - 1,278) 2003 Modelled IHME, GBD 2019 (accessed 2022)
900 (632 - 1,237) 2002 Modelled IHME, GBD 2019 (accessed 2022)
884 (620 - 1,207) 2001 Modelled IHME, GBD 2019 (accessed 2022)
873 (617 - 1,201) 2000 Modelled IHME, GBD 2019 (accessed 2022)
860 (609 - 1,180) 1999 Modelled IHME, GBD 2019 (accessed 2022)
842 (600 - 1,143) 1998 Modelled IHME, GBD 2019 (accessed 2022)
819 (591 - 1,101) 1997 Modelled IHME, GBD 2019 (accessed 2022)
790 (576 - 1,047) 1996 Modelled IHME, GBD 2019 (accessed 2022)
761 (562 - 1,009) 1995 Modelled IHME, GBD 2019 (accessed 2022)
733 (542 - 973) 1994 Modelled IHME, GBD 2019 (accessed 2022)
714 (529 - 945) 1993 Modelled IHME, GBD 2019 (accessed 2022)
691 (521 - 908) 1992 Modelled IHME, GBD 2019 (accessed 2022)
661 (501 - 858) 1991 Modelled IHME, GBD 2019 (accessed 2022)
639 (482 - 829) 1990 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
11 (8 - 14) 1991 Modelled IHME, GBD 2019 (accessed 2022)
11 (7 - 14) 1992 Modelled IHME, GBD 2019 (accessed 2022)
11 (8 - 14) 1990 Modelled IHME, GBD 2019 (accessed 2022)
11 (7 - 14) 1994 Modelled IHME, GBD 2019 (accessed 2022)
11 (7 - 14) 1993 Modelled IHME, GBD 2019 (accessed 2022)
11 (7 - 14) 1995 Modelled IHME, GBD 2019 (accessed 2022)
11 (8 - 14) 1996 Modelled IHME, GBD 2019 (accessed 2022)
11 (8 - 14) 1998 Modelled IHME, GBD 2019 (accessed 2022)
11 (8 - 14) 1999 Modelled IHME, GBD 2019 (accessed 2022)
11 (8 - 14) 1997 Modelled IHME, GBD 2019 (accessed 2022)
11 (8 - 15) 2000 Modelled IHME, GBD 2019 (accessed 2022)
12 (8 - 15) 2001 Modelled IHME, GBD 2019 (accessed 2022)
12 (9 - 15) 2002 Modelled IHME, GBD 2019 (accessed 2022)
11 (8 - 14) 2003 Modelled IHME, GBD 2019 (accessed 2022)
11 (8 - 14) 2005 Modelled IHME, GBD 2019 (accessed 2022)
11 (8 - 15) 2004 Modelled IHME, GBD 2019 (accessed 2022)
10 (8 - 14) 2006 Modelled IHME, GBD 2019 (accessed 2022)
11 (8 - 14) 2007 Modelled IHME, GBD 2019 (accessed 2022)
14 (11 - 18) 2008 Modelled IHME, GBD 2019 (accessed 2022)
15 (11 - 19) 2009 Modelled IHME, GBD 2019 (accessed 2022)
17 (12 - 21) 2010 Modelled IHME, GBD 2019 (accessed 2022)
20 (15 - 26) 2012 Modelled IHME, GBD 2019 (accessed 2022)
18 (13 - 23) 2011 Modelled IHME, GBD 2019 (accessed 2022)
22 (16 - 28) 2013 Modelled IHME, GBD 2019 (accessed 2022)
21 (16 - 27) 2014 Modelled IHME, GBD 2019 (accessed 2022)
22 (16 - 28) 2016 Modelled IHME, GBD 2019 (accessed 2022)
22 (16 - 28) 2015 Modelled IHME, GBD 2019 (accessed 2022)
22 (16 - 29) 2017 Modelled IHME, GBD 2019 (accessed 2022)
26 (19 - 34) 2018 Modelled IHME, GBD 2019 (accessed 2022)
27 (19 - 35) 2019 Modelled IHME, GBD 2019 (accessed 2022)
36 (27 - 45) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2017
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes
Source: WHO
Year of birth dose introduction
2004
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
No
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
No
Source: Harm Reduction International
NSP in at least one prison
No
Source: Harm Reduction International
OST in at least one prison
No
Source: Harm Reduction International
% of substance use disorder facilities offering hepatitis testing
Most (61-100%)
Source: WHO
% of substance use disorder facilities offering hepatitis treatment
Most (61-100%)
Source: WHO

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

HBV (HBsAg+)
1.98 (%)
2019
(1.62 - 2.31(%))
IHME, GBD 2019 (accessed 2020)
HCV (RNA/cAg+)
1.16 (%)
2019
(0.94 - 1.45(%))
IHME, GBD 2019 (accessed 2022)

Survey/surveillance

No data available
HCV (anti-HCV)
3.2 (%)
2014
(0.3 - 3.2(%))
Gower et al, 2014

Hepatitis related deaths (national)

Modelled

HBV
1,094
2019
(801 - 1,460)
IHME, GBD 2019 (accessed 2022)

Survey/surveillance

No data available
HBV chart

Modelled

HCV
1,660
2019
(1,217 - 2,152)
IHME, GBD 2019 (accessed 2020)

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
0.29 (%)
2020, latest modelled
(0.14 - 0.54(%))
WHO

Prevalence PWID

No data available

Birth dose vaccination coverage (national)

Survey/surveillance

HBV
48 (%)
2021
WHO/UNICEF

No. of syringes/PWID/year

Survey/surveillance

HCV
0
2016
(0 - 0)
Harm Reduction International, 2016
Eligible for HBV generic medicines
Eligible for HCV generic medicines

Resources